UNIV - Research Study Coordinator - Hollings Cancer Center

Medical University Hospital Authority (MUHA); South Carolina; On-site; USD 46,000 - 79,000; Full time

Job summary

The Medical University of South Carolina (MUSC) Hollings Cancer Center seeks a clinical trials coordinator to support NCI and industry oncology trials. Under CTO supervision, you will coordinate, establish, and supervise complex protocols and ensure proper study participant management.

Your role includes data entry in CTMS and EPIC, patient screening and enrollment, collaboration with physicians and nurses, and adherence to OSHA guidelines for specimen handling.

Qualifications

• Clinical trials coordination and management experience preferred.
• Familiarity with CTMS, EPIC, and data entry for research studies.
• Ability to communicate with physicians, nurses and patients clearly.

Responsibilities

• Coordinate patient research activities to meet protocol requirements and ensure protocol compliance.
• Assist with patient screening, enrollment, and follow-up, reporting status changes in CTMS/EPIC within 24 hours.
• Maintain study documentation, coordinate specimen handling per OSHA guidelines, and support tumor boards and clinics.

Job description

Job Description Summary

Under general supervision of the Clinical Trials Office (CTO) and specific disease group Program Manager within the Clinical Operations Unit, this position coordinates, establishes, and supervises complex research protocols at the Hollings Cancer Center (HCC) to efficiently and effectively integrate the National Cancer Institute (NCI), investigator initiated and industry sponsored oncology trials at the Medical University of South Carolina (MUSC). Actively promotes and increases awareness of the clinical trial program within HCC, exercises judgment regarding proper study participant management.

EntityMedical University of South Carolina (MUSC - Univ)

Worker TypeEmployee

Worker Sub-TypeResearch Grant

Cost CenterCC001332 HCC CTO Administration

Pay Rate TypeHourly

Pay GradeUniversity-GEN08

Pay Range

• 46,206.00
• 62,322.00
• 78,540.000

Scheduled Weekly Hours40

Work Shift

Job Description

Under general supervision of the Clinical Trials Office (CTO) and specific disease group Program Manager within the Clinical Operations Unit, this position coordinates, establishes, and supervises complex research protocols at the Hollings Cancer Center (HCC) to efficiently and effectively integrate the National Cancer Institute (NCI), investigator initiated and industry sponsored oncology trials at the Medical University of South Carolina (MUSC). Actively promotes and increases awareness of the clinical trial program within HCC, exercises judgment regarding proper study participant management.

Responsibilities:

• 35% Coordinates patient research related activities to accurately meet protocol requirements. Ensure protocol compliance for study participants. Ensures database updates to reflect accurate patient status. Utilizes office tools including Sharepoint, Clinical Data Center (CDC) , and clinical trial management system (CTMS). Provides protocol specific information to physicians, primary nurses, and patients. Coordinates the clinical work-up to determine patient eligibility. Coordinates treatment plan and required follow-up with study participant, medical staff, nursing staff and ancillary hospital personnel. Ensures that follow-up requirements per protocol are carried out in order to assess for response to treatment. Works closely with clinical nurse staff to coordinate patient care to meet protocol standards. Consults with the investigator to assess study participant for response to protocol therapy including toxicity assessment and disease status. Coordinates and conducts activities associated with the preparation and shipment of protocol related samples within specified parameters. Prepares, transports, and handles bloodborne pathogens and other human specimens following OSHA guidelines. Enters and maintains both current and new study participant information into the clinical trials database. New patient enrollments and status updates are to be entered into the CTMS within 24 hours of the enrollment or status change. This includes Screening, Screen Failures, Consenting, Enrolling, Active on Treatment, Follow up, and Off study status. New patient enrollments and status updates are to be entered/confirmed in EPIC within 24 hours of the enrollment and or status change. This includes Consented- in screening, Enrolled-Receiving treatment and/or intervention, Enrolled-follow up only, Lost to follow up, Screen failure and Completed. Research participant protocol-related visits must be linked in EPIC prior to the encounter.
• 20% Assists investigators to identify, consent, screen, register/ enroll eligible patients to studies at Hollings Cancer Center. Screens all patients at the Hollings Cancer Center (HCC) that have been newly diagnosed, have progressed, or experienced a recurrence to potentially be included into a clinical trial. Attends and actively participates in regularly scheduled multidisciplinary tumor boards, clinics, conferences, and any other forum where patients may be discussed. Documents and tracks all screening efforts per departmental guidelines. Establishes communication with physician investigators and care team regarding potential study participants. Effective screening of HCC patient medical records requires knowledge of oncology terminology, medical terminology, disease specific staging and each clinical trial protocol eligibility criterion. Meets weekly with their clinical operations team to discuss potential trial participants and plan for the upcoming week for all clinic coverage needs. Under guidance of the team lead coordinator(s) and program manager, will support research activities at any of the MUSC main campus and HCC satellite locations and make necessary coverage plans in advance, to avoid interruption of quality CTO services. Participates in and supports the informed consent process per departmental and institutional policy.
• 20% Timely and accurately collects and submits data to established research bases including the National Cancer Institute, industry sponsors

20% Timely and accurately collects and submits data to established research bases including the National Cancer Institute, industry sponsors